Gemini Therapeutics, Inc.
297 Boston Post Road #248
Wayland, MA 01778
December 1, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|
Attention:
|
Jessica Ansart
|
|
Abby Adams
|
|
|
Tara Harkins
|
|
|
Brian Cascio
|
|
Re:
|
Gemini Therapeutics, Inc.
Registration Statement on Form S-4
File No. 333-267276
Request for Acceleration
|
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Gemini Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-267276), as
amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on December 2, 2022, or as soon thereafter as practicable.
|
Very truly yours,
|
|||
|
GEMINI THERAPEUTICS, INC.
|
|||
|
By:
|
/s/ Georges Gemayel
|
||
|
Name:
|
Georges Gemayel
|
||
|
Title:
|
Interim President and Chief Executive Officer
|
||